Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03111147 · ClinicalTrials.gov registry record · NA
Impact of Humeral Component Version on Outcomes Following RTSA
A NA study, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT03111147: Completed NA study, sponsored by Corewell Health East.
NCT03111147 is a NA study that has completed, run by Corewell Health East. The registered enrollment target is 95 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03111147, a NA study, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
The proposed study is a prospective, single-blinded, randomized trial to investigate the impact of humeral component version on shoulder range of motion and patient reported functional outcomes following reverse total shoulder arthroplasty.
Primary Outcome
External range of motion measurements of the shoulder in degrees
Interventions
- DEVICE 0 degrees humeral component version
- DEVICE 30 degrees humeral component retroversion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2017-05-12 |
| Est. Completion | 2023-05-23 |
| Phase | NA |
What the finished NCT03111147 record still lists
NCT03111147 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which 0 degrees humeral component version is the first listed.
NCT03111147 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03111147 about?
NCT03111147 is a clinical study titled "Impact of Humeral Component Version on Outcomes Following RTSA". The proposed study is a prospective, single-blinded, randomized trial to investigate the impact of humeral component version on shoulder range of motion and patient reported functional outcomes following reverse total shoulder arthroplasty.
What is the current status of trial NCT03111147?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2017-05-12. Estimated completion is 2023-05-23.
What interventions are being tested in trial NCT03111147?
The interventions under investigation include: 0 degrees humeral component version (DEVICE), 30 degrees humeral component retroversion (DEVICE).
Who is sponsoring clinical trial NCT03111147?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03111147's enrollment target sits among peer trials
95 931st of 2000 higher than 1,066 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI